Why Shares of Sage Therapeutics Climbed 15.6% This Week
Copyright 1995-2022 The Motley Fool. All rights reserved.
finance
2022-06-03 22:20:00

Shares of Sage Therapeutics (SAGE 0.60%), a biopharmaceutical company that specializes in brain disorder therapies, saw its shares rise 15.6% this week, according to data from S&P Global Market Intelligence. The stock closed last Friday at $32.24 but rose to $37.27 this Friday. Overall, the stock is down more than 13% this year. Its 52-week low is $27.36, and it has a 52-week high of $79.45.

Image source: Getty Images.

So what
The company announced on Wednesday that zuranolone, a drug it is developing with Biogen,Â had met its primary endpoints in a phase 3 study to treat women with postpartum depression.
